Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 369

1.

Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.

Liu Y, Bodmer WF.

Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):976-81. Epub 2006 Jan 17.

2.

Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines.

Wasielewski M, Elstrodt F, Klijn JG, Berns EM, Schutte M.

Breast Cancer Res Treat. 2006 Sep;99(1):97-101. Epub 2006 Mar 16.

PMID:
16541312
3.

p53 mutations in bladder carcinoma cell lines.

Cooper MJ, Haluschak JJ, Johnson D, Schwartz S, Morrison LJ, Lippa M, Hatzivassiliou G, Tan J.

Oncol Res. 1994;6(12):569-79.

PMID:
7787250
4.

p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.

Hernandez L, Fest T, Cazorla M, Teruya-Feldstein J, Bosch F, Peinado MA, Piris MA, Montserrat E, Cardesa A, Jaffe ES, Campo E, Raffeld M.

Blood. 1996 Apr 15;87(8):3351-9.

5.

Aberrant p53 protein expression and function in a panel of hematopoietic cell lines with different p53 mutations.

Kamihira S, Terada C, Sasaki D, Yanagihara K, Tsukasaki K, Hasegawa H, Yamada Y.

Eur J Haematol. 2009 Apr;82(4):301-7. doi: 10.1111/j.1600-0609.2009.01211.x. Epub 2008 Jan 29.

PMID:
19220422
6.

Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.

Kameyama K, Huang CL, Liu D, Masuya D, Nakashima T, Sumitomo S, Takami Y, Kinoshita M, Yokomise H.

Clin Cancer Res. 2003 Oct 15;9(13):4926-34.

7.

High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.

Holstege H, Joosse SA, van Oostrom CT, Nederlof PM, de Vries A, Jonkers J.

Cancer Res. 2009 Apr 15;69(8):3625-33. doi: 10.1158/0008-5472.CAN-08-3426. Epub 2009 Mar 31.

8.

mRNA and protein expression of p53 mutations in human bladder cancer cell lines.

Kawasaki T, Tomita Y, Watanabe R, Tanikawa T, Kumanishi T, Sato S.

Cancer Lett. 1994 Jul 15;82(1):113-21.

PMID:
8033064
9.

Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation.

Schneider BG, John-Aryankalayil M, Rowsey JJ, Dushku N, Reid TW.

Exp Eye Res. 2006 Jan;82(1):91-8. Epub 2005 Jul 11.

PMID:
16005868
10.

P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.

Forslund A, Kressner U, Lönnroth C, Andersson M, Lindmark G, Lundholm K.

Int J Oncol. 2002 Aug;21(2):409-15.

PMID:
12118339
11.

Association of p53 mutations, microvessel density and neoangiogenesis in pairs of colorectal cancers and corresponding liver metastases.

Kern A, Taubert H, Scheele J, Rudroff C, Mothes H, Kappler M, Bartel F, Richter KK.

Int J Oncol. 2002 Aug;21(2):243-9.

PMID:
12118317
12.
13.

P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.

de Jong KP, Gouw AS, Peeters PM, Bulthuis M, Menkema L, Porte RJ, Slooff MJ, van Goor H, van den Berg A.

Clin Cancer Res. 2005 Jun 1;11(11):4067-73.

14.
15.

p53 splice acceptor site mutation and increased HsRAD51 protein expression in Bloom's syndrome GM1492 fibroblasts.

Magnusson KP, Sandström M, Ståhlberg M, Larsson M, Flygare J, Hellgren D, Wiman KG, Ljungquist S.

Gene. 2000 Apr 4;246(1-2):247-54.

PMID:
10767546
16.
17.

Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation.

Bodner SM, Minna JD, Jensen SM, D'Amico D, Carbone D, Mitsudomi T, Fedorko J, Buchhagen DL, Nau MM, Gazdar AF, et al.

Oncogene. 1992 Apr;7(4):743-9.

PMID:
1565469
18.

High resolution melting for mutation scanning of TP53 exons 5-8.

Krypuy M, Ahmed AA, Etemadmoghadam D, Hyland SJ; Australian Ovarian Cancer Study Group., DeFazio A, Fox SB, Brenton JD, Bowtell DD, Dobrovic A.

BMC Cancer. 2007 Aug 31;7:168.

19.

Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.

Baumbusch LO, Myhre S, Langerød A, Bergamaschi A, Geisler SB, Lønning PE, Deppert W, Dornreiter I, Børresen-Dale AL.

Mol Cancer. 2006 Oct 20;5:47.

20.

Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines.

Reiss M, Brash DE, Muñoz-Antonia T, Simon JA, Ziegler A, Vellucci VF, Zhou ZL.

Oncol Res. 1992;4(8-9):349-57.

PMID:
1486218

Supplemental Content

Support Center